| Literature DB >> 19188460 |
M J M H Lombarts1, I Rupp, P Vallejo, N S Klazinga, R Suñol.
Abstract
AIM: This study, part of the Methods of Assessing Response to Quality Improvement Strategies (MARQuIS) research project focusing on cross-border patients in Europe, investigated quality policies and improvement in healthcare systems across the European Union (EU). The aim was to develop a classification scheme for the level of quality improvement (maturity) in EU hospitals, in order to evaluate hospitals according to the maturity of their quality improvement activities.Entities:
Mesh:
Year: 2009 PMID: 19188460 PMCID: PMC2629850 DOI: 10.1136/qshc.2008.029389
Source DB: PubMed Journal: Qual Saf Health Care ISSN: 1475-3898
Principles for coding and recoding items in the quality improvement (QI) maturity index
| Stage of quality improvement maturity level | |||
| 1 (Most mature) | 2 | 3 | 4 (Least mature) |
| External assessment | Written reports of activities | Policies | No |
| Internal audits | Implementation of quality and safety activities, ie: | QI plans | |
| Professionals formally approve policies | Periodic and systematic evaluation of data collected in laboratories | Strategies | |
| Accountability | Regular calibration or maintenance equipment | Staff responsibility for QI activities | |
| Feedback to staff and board | Internal budget for QI | Quality or safety teams or committees | |
| Review and use of indicator data | |||
Construction of the quality improvement (QI) maturity index in seven domains and 113 items
| Domain | Number of items included | Cronbach α |
| Policy, planning, documents | 20 | 0.86 |
| Leadership | 36 | 0.89 |
| Structure | 19 | 0.69 |
| QI activities | 8 | 0.75 |
| QI activities (laboratories) | 20 | 0.85 |
| Patient involvement | 6 | 0.82 |
| Accountability | 4 | 0.54 |
| Total | 113 | 0.72 |
Correlations (Spearman ρ) between the domains of the quality improvement (QI) maturity index, and between other domains and the index
| Policy | Leadership | Structure | QI activities | QI activities (laboratories) | Patient involvement | Accountability | QI maturity index | |
| Policy | 1.0 | 0.726* | ||||||
| Leadership | 0.469* | 1.0 | 0.686* | |||||
| Structure | 0.730* | 0.498* | 1.0 | 0.664* | ||||
| QI activities | 0.564* | 0.489* | 0.515* | 1.0 | 0.766* | |||
| QI activities (laboratories) | 0.516* | 0.304* | 0.499* | 0.478* | 1.0 | 0.615* | ||
| Patient involvement | 0.20* | 0.108 | 0.215* | 0.242* | − | 1.0 | 0.402* | |
| Accountability | 0.238* | 0.275* | 0.185* | 0.257* | 0.217* | 0.090 | 1.0 | 0.553* |
*p = 0.01.
Variance in overall quality improvement maturity classification scores, and distribution of scores
| Country | Variance in maturity classification score* | Maturity classification scores (based on quartiles) | |||
| Min score | Max score | Most mature (⩽25%) | Intermediate maturity (>25%–75%) | Least mature(>75%) | |
| Belgium (n = 24) | 2.10 | 3.10 | 3 | 16 | 5 |
| Czech Republic (n = 38) | 1.50 | 3.00 | 10 | 22 | 8 |
| France (n = 65) | 1.87 | 3.25 | 11 | 32 | 22 |
| Ireland (n = 23) | 1.90 | 3.08 | 8 | 12 | 3 |
| The Netherlands (n = 8) | 2.09 | 2.52 | 4 | 4 | – |
| Poland (n = 76) | 1.86 | 3.45 | 22 | 33 | 21 |
| Spain (n = 105) | 1.70 | 3.26 | 20 | 55 | 30 |
| UK (n = 10) | 1.77 | 2.37 | 9 | 1 | – |
| Total (n = 349) | 1.50 | 3.45 | 87 | 175 | 87 |
*Low scores reflect higher maturity.
Validation of the quality improvement maturity index through hypotheses testing
| Hypotheses tested: output was related with maturity of the hospital’s QI system | Operationalisation of values tested | Distribution of QI maturity classification (mean scores) | |||
| Number of items included(Cronbach α; n) | Significant at p level | Most mature(⩽25%) | Least mature(>75%) | Total | |
| External pressure | 9 (0.68; n = 126) | <0.001 | 1.71 (n = 78) | 2.75 (n = 76) | 2.25 (n = 310) |
| Safety* | 4 (0.24; n = 313) | <0.001 | 1.38 (n = 86) | 1.53 (n = 85) | 1.44 (n = 349) |
| Support for cross-border care patients | 6 (0.61; n = 298) | <0.001 | 1.60 (n = 86) | 1.76 (n = 84) | 1.96 (n = 346) |
| Distribution of quality improvement maturity classification (%) | |||||
| Availability of AMI indicator: door-to-needle time: % yes | 1 | 0.10 | 65.2 | 47.3 | 57.5 |
| Availability of AMI indicator: aspirin <24 h after AMI: % yes | 1 | 0.03 | 82.4 | 64.0 | 71.4 |
*To avoid overlap contamination in the measures and output, a modified QI maturity index was computed excluding all items related to safety.
Agreement between quality improvement (QI) maturity index classification and assessments of independent surveyors*
| Evaluator scale | Least mature n (%) | Most mature n (%) |
| Least developed QI | 11 (84.6) | 2 (15.4) |
| 18 (85.7) | 3 (14.3) | |
| Intermediate | 13 (46.4) | 15 (53.6) |
| 10 (25.0) | 30 (75.0) | |
| Most developed QI | 0 | 6 (100) |
| Total | 52 (48.1) | 56 (51.9) |
*In general, two surveyors audited each hospital. Their responses were included independently in the analysis (either both gave the same response, or each gave a different one). Some hospitals were audited by only one surveyor, and not all of them provided a maturity rating.